Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.
2.

Long-term vasodilator therapy in patients with severe aortic regurgitation.

Evangelista A, Tornos P, Sambola A, Permanyer-Miralda G, Soler-Soler J.

N Engl J Med. 2005 Sep 29;353(13):1342-9.

3.

Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function.

Scognamiglio R, Rahimtoola SH, Fasoli G, Nistri S, Dalla Volta S.

N Engl J Med. 1994 Sep 15;331(11):689-94.

4.

Angiotensin II-converting enzyme inhibition improves survival, ventricular remodeling, and myocardial energetics in experimental aortic regurgitation.

Arsenault M, Zendaoui A, Roussel E, Drolet MC, Dhahri W, Grenier A, Gascon S, Sarrhini O, Rousseau JA, Lecomte R, Couet J.

Circ Heart Fail. 2013 Sep 1;6(5):1021-8. doi: 10.1161/CIRCHEARTFAILURE.112.000045. Epub 2013 Jul 16.

5.

Survival benefit of aortic valve replacement in older patients with asymptomatic chronic severe aortic regurgitation.

Turk R, Varadarajan P, Kamath A, Sampat U, Khandhar S, Patel R, Pai RG.

Ann Thorac Surg. 2010 Mar;89(3):731-7. doi: 10.1016/j.athoracsur.2009.12.008.

PMID:
20172118
6.

Effects of long-term vasodilator therapy on electrocardiographic abnormalities in chronic aortic regurgitation.

Wilson R, Perlmutter N, Jacobson N, Siemienczuk D, Szlachcic J, Bristow JD, Cheitlin M, Massie B, Greenberg B.

Am J Cardiol. 1991 Oct 1;68(9):935-9.

PMID:
1927953
7.

Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation.

Plante E, Lachance D, Beaudoin J, Champetier S, Roussel E, Arsenault M, Couet J.

Circ Heart Fail. 2009 Jan;2(1):25-32. doi: 10.1161/CIRCHEARTFAILURE.108.801548.

8.

Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves.

Levine HJ, Gaasch WH.

J Am Coll Cardiol. 1996 Nov 1;28(5):1083-91. Review.

9.

Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy.

Lin M, Chiang HT, Lin SL, Chang MS, Chiang BN, Kuo HW, Cheitlin MD.

J Am Coll Cardiol. 1994 Oct;24(4):1046-53.

10.

Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation.

Plante E, Gaudreau M, Lachance D, Drolet MC, Roussel E, Gauthier C, Lapointe E, Arsenault M, Couet J.

Can J Physiol Pharmacol. 2004 Mar;82(3):191-9.

PMID:
15052285
12.

Usefulness of preoperative stroke volume as strong predictor of left ventricular remodeling and outcomes after aortic valve replacement in patients with severe pure aortic regurgitation.

Sénéchal M, Bernier M, Dagenais F, Dubois M, Dubois-Sénéchal IN, Voisine P.

Am J Cardiol. 2011 Oct 1;108(7):1008-13. doi: 10.1016/j.amjcard.2011.05.035. Epub 2011 Jul 27.

PMID:
21798497
13.

Characterization of coronary flow reserve and left ventricular remodeling in a mouse model of chronic aortic regurgitation with carvedilol intervention.

Wang X, Wu J, Zhu D, You J, Zou Y, Qian J, Ge J.

J Ultrasound Med. 2015 Mar;34(3):483-93. doi: 10.7863/ultra.34.3.483.

PMID:
25715369
14.

Factors influencing recovery of left ventricular structure in patients with chronic heart failure.

Duan HY, Wu XS, Han ZH, Guo YF, Fang SJ, Zhang XX, Wang CM.

Chin Med J (Engl). 2011 Sep;124(18):2868-73.

15.

Benefits of long-term beta-blockade in experimental chronic aortic regurgitation.

Plante E, Lachance D, Champetier S, Drolet MC, Roussel E, Arsenault M, Couet J.

Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1888-95. doi: 10.1152/ajpheart.01286.2007. Epub 2008 Feb 22.

16.

Predictors of preserved left ventricular systolic function after surgery for chronic organic mitral regurgitation: a prospective study.

Gelfand EV, Haffajee JA, Hauser TH, Yeon SB, Goepfert L, Kissinger KV, Delatorre R, Manning WJ.

J Heart Valve Dis. 2010 Jan;19(1):43-50.

PMID:
20329489
17.

[Left ventricular function in post-endocarditis aortic insufficiency and aortic-annular ectasia].

Klipstein A, Hug R, Turina J, Jenni R, Hess OM.

Schweiz Med Wochenschr. 1995 Aug 8;125(31-32):1469-76. German.

PMID:
7676236
18.

Effectiveness of angiotensin-converting enzyme inhibitors in pediatric patients with mid to severe aortic valve regurgitation.

Gisler F, Knirsch W, Harpes P, Bauersfeld U.

Pediatr Cardiol. 2008 Sep;29(5):906-9. doi: 10.1007/s00246-008-9228-x. Epub 2008 Apr 10.

PMID:
18401634
19.

Effects of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation.

Schön HR, Dorn R, Barthel P, Schömig A.

J Heart Valve Dis. 1994 Sep;3(5):500-9.

PMID:
8000584
20.

Vasodilator therapy in patients with aortic insufficiency: a systematic review.

Mahajerin A, Gurm HS, Tsai TT, Chan PS, Nallamothu BK.

Am Heart J. 2007 Apr;153(4):454-61. Review.

PMID:
17383279

Supplemental Content

Support Center